Table 2.
Morphological parameter | Control | Control + R | STZ | STZ + R | Cort, 400 μg/ml |
---|---|---|---|---|---|
Total MFT profile area, μm2 | 5.12 ± 0.24 | 5.40 ± 0.30 | 5.76 ± 0.34 | 5.64 ± 0.41 | 7.24 ± 0.23* |
Mit profile area/MFT profile, μm2 | 0.28 ± 0.01 | 0.26 ± 0.04 | 0.40 ± 0.04*† | 0.28 ± 0.03 | 0.28 ± 0.04 |
% decrease synaptic vesicle | — | 2.64 ± 0.18 | 21.05 ± 1.80‡ | 42.99 ± 2.99§ | 39.20 ± 0.31§ (85% of MFT) |
density | 2.80 ± 0.20 (15% of MFT) |
* and
, P < 0.05 compared with control, control + restraint groups, and STZ + restraint group;
and
, P < 0.05 and 0.01, compared with control and control + restraint groups. One-way ANOVA, Tukey post hoc test. No significant differences between controls and controls receiving 2.4% ethanol (see Materials and Methods) were detected. No significant differences on number or area of spine profiles or number of mitochondria/MFT profile were detected among experimental treatment groups (data not shown). R, restraint stress.